Cerebral angiography is a medical imaging technique used to visualize the arteries and veins in the brain and neck. It helps in the diagnosis of various neurological conditions such as aneurysms, brain tumors, head and neck injuries, stroke and vascular malformations. The procedure involves inserting a catheter into an artery, usually in the groin, and guiding it up into the arteries supplying the head and neck. Once in place, a contrast agent is injected and X-rays are taken to monitor the flow of blood and identify any abnormalities. Cerebral angiography provides precise anatomical details and is considered the gold standard for diagnosing many neurovascular diseases.

The global cerebral angiography market is estimated to be valued at US$ 14.96 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The increasing prevalence of neurovascular diseases is fueling the growth of the Global Cerebral Angiography Market Size  Neurovascular diseases such as ischemic strokes, cerebral aneurysms and arteriovenous malformations are on the rise globally due to aging population and risk factors like hypertension, diabetes, smoking and physical inactivity. According to the World Stroke Organization, stroke is the second leading cause of death worldwide. Cerebral angiography plays a key role in accurately diagnosing these conditions and helping physicians determine the appropriate treatment plan. With growing disease burden, the demand for cerebral angiography procedures is expected to surge significantly over the forecast period. This presents lucrative opportunities for players in the cerebral angiography market to develop advanced imaging systems and expand their geographical presence to tap the revenue potential in emerging markets.

Porter’s Analysis

Threat of new entrants: Low barriers to entry, established distribution networks and technological expertise of incumbent companies make entry difficult for new players.

Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of substitutes and bargaining power of large healthcare providers.

Bargaining power of suppliers: Suppliers have low to moderate bargaining power as raw materials used are generally commodity chemicals and there exist alternatives.

Threat of new substitutes: Threat of substitutes is low as Cerebral Angiography provides unique benefits over other neuroimaging techniques.

Competitive rivalry: The market is highly competitive with major players differentiating based on technology, brand, and geographic presence.

SWOT Analysis

Strengths: Non-invasive visualization technique, growing aging population base increasing demographic of target customers.

Weaknesses: Requires highly skilled professionals, risk of complications if improperly performed, availability of substitutes.

Opportunities: Untapped growth potential in developing regions, scope for innovation in minimally invasive surgeries.

Threats: Stringent regulatory approvals, reimbursement cuts affecting pricing flexibility.

Get More Insights On This Topic: https://www.feedsfloor.com/other/cerebral-angiography-market-estimated-witness-high-growth-owing-increasing-prevalence